Tapewire

Nasdaq · USD

IDXX

IDEXX LABORATORIES INC /DE

Export transactions ↓
Tapewire entity
3057
SEC CIK
0000874716
Parsed reports
597

Last 12 months

Inside the activity.

0 purchase rows · 36 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202500
Jan 202600
Feb 2026030
Mar 202601
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 04, 2023 Filed May 5, 2023 22:01 UTC SaleCommon Stock 2,187 $469.02 $1,025,739.96
Disclosure

SEC source: 0000874716-23-000039 · wf-form4_168332406840001.xml · nonDerivative · entry 2

Vandebroek Sophie V. · CIK 0001442078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 872

F1 · price: Represents the weighted average price of the shares sold ranging from a low of $469.00 to a high of $469.15 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
May 04, 2023 Filed May 5, 2023 22:01 UTC Exercise / conversionCommon Stock 2,187 $206.62 $451,877.94
Disclosure

SEC source: 0000874716-23-000039 · wf-form4_168332406840001.xml · nonDerivative · entry 1

Vandebroek Sophie V. · CIK 0001442078 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 04, 2023 Filed May 5, 2023 22:00 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
Exercise / conversionIncentive Stock Option (right-to-buy) · Derivative 560 Not disclosed Strike: $178.26 Not disclosed
Disclosure

SEC source: 0000874716-23-000038 · wf-form4_168332400555957.xml · derivative · entry 2

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 560 shares

Expires 2028-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: Grant of option to buy shares of Issuer common stock that became exercisable on the fifth anniversary of the date of grant.

Read SEC document
May 04, 2023 Filed May 5, 2023 22:00 UTC
MAZELSKY JONATHAN JAYDirector · President and CEO
Exercise / conversionCommon Stock 560 $178.26 $99,825.60
Disclosure

SEC source: 0000874716-23-000038 · wf-form4_168332400555957.xml · nonDerivative · entry 1

MAZELSKY JONATHAN JAY · CIK 0001556270 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,301.3456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 14.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023.

Read SEC document
May 04, 2023 Filed May 8, 2023 21:00 UTC GiftCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0000874716-23-000040 · wf-form4_168357960657042.xml · nonDerivative · entry 1

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,519

Read SEC document
April 28, 2023 Filed May 2, 2023 22:01 UTC GrantCommon Stock 13 $492.16 $6,398.08
Disclosure

SEC source: 0000874716-23-000035 · wf-form4_168306488969915.xml · nonDerivative · entry 1

JUNIUS DANIEL M · CIK 0001094159 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,995

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($6,562.50) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock as soon as practicable following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:06 UTC Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 2,187 Not disclosed Strike: $206.62 Not disclosed
Disclosure

SEC source: 0001567619-23-003312 · doc1.xml · derivative · entry 3

JUNIUS DANIEL M · CIK 0001094159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,187 shares

Expires 2028-05-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: Not applicable.

F2 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 8, 2019, the date of the 2019 annual meeting of shareholders.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:06 UTC SaleCommon Stock 2,187 $511.68 $1,119,043.50
Disclosure

SEC source: 0001567619-23-003312 · doc1.xml · nonDerivative · entry 2

JUNIUS DANIEL M · CIK 0001094159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,982

F1 · price: Represents the weighted average price of the shares sold ranging from a low of $511.65 to a high of $512.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:06 UTC Exercise / conversionCommon Stock 2,187 $206.62 $451,877.94
Disclosure

SEC source: 0001567619-23-003312 · doc1.xml · nonDerivative · entry 1

JUNIUS DANIEL M · CIK 0001094159 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 10 Not disclosed Strike: $79.54 Not disclosed
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · derivative · entry 7

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,726

Underlying: Common Stock · 10 shares

Expires 2025-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Not applicable.

F3 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 10 $515.58 $5,155.75
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · nonDerivative · entry 4

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,379.8492

Read SEC document
February 16, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 10 $79.54 $795.40
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · nonDerivative · entry 3

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,389.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 16, 2023 Filed Feb 21, 2023 22:00 UTC GiftCommon Stock 1,000 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003421 · doc1.xml · nonDerivative · entry 1

AYERS JONATHAN W · CIK 0001184149 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,520

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 1,000 Not disclosed Strike: $79.54 Not disclosed
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · derivative · entry 6

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,736

Underlying: Common Stock · 1,000 shares

Expires 2025-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: Not applicable.

F3 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 1,000 $510.03 $510,031.20
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · nonDerivative · entry 2

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,379.8492

F1 · price: Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 15, 2023 Filed Feb 17, 2023 22:04 UTC
Turner Kathy VSenior Vice President
GrantCommon Stock 1,000 $79.54 $79,540.00
Disclosure

SEC source: 0001567619-23-003311 · doc1.xml · nonDerivative · entry 1

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,379.8492

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionRestricted Stock Unit · Derivative 173 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 9

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,197

Underlying: Common Stock · 173 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F5 · price: Not applicable.

F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionRestricted Stock Unit · Derivative 138 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 8

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,370

Underlying: Common Stock · 138 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F5 · price: Not applicable.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionRestricted Stock Unit · Derivative 216 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 7

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,508

Underlying: Common Stock · 216 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F5 · price: Not applicable.

F2 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F2 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionRestricted Stock Unit · Derivative 483 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · derivative · entry 6

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,724

Underlying: Common Stock · 483 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F5 · price: Not applicable.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Tax withholdingCommon Stock 305 $503.65 $153,613.25
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 5

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,746.9949

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionCommon Stock 173 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 4

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,051.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionCommon Stock 138 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 3

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,878.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionCommon Stock 216 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 2

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,740.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Underberg Sharon E.EVP, GC & Corp. Secretary
Exercise / conversionCommon Stock 483 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003224 · doc1.xml · nonDerivative · entry 1

Underberg Sharon E. · CIK 0001630353 · EVP, GC & Corp. Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,524.9949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionNon-Qualified Stock Option (right-to-buy) · Derivative 2,000 Not disclosed Strike: $79.54 Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 18

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,736

Underlying: Common Stock · 2,000 shares

Expires 2025-02-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F12 · price: Not applicable.

F11 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 4,993 shares in five annual installments beginning February 15, 2016, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionRestricted Stock Unit · Derivative 93 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 17

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 793

Underlying: Common Stock · 93 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F12 · price: Not applicable.

F10 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F10 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionRestricted Stock Unit · Derivative 86 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 16

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 886

Underlying: Common Stock · 86 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F12 · price: Not applicable.

F9 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F9 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionRestricted Stock Unit · Derivative 162 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 15

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 972

Underlying: Common Stock · 162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F12 · price: Not applicable.

F8 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F8 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionRestricted Stock Unit · Derivative 181 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 14

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,134

Underlying: Common Stock · 181 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F12 · price: Not applicable.

F7 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F7 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionRestricted Stock Unit · Derivative 210 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · derivative · entry 13

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,315

Underlying: Common Stock · 210 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

F12 · price: Not applicable.

F6 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

F6 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 110 $502.81 $55,309.54
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 11

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,379.8492

F4 · price: Represents the weighted average price of the shares sold ranging from a low of $502.42 to a high of $503.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 577 $504.09 $290,861.26
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 10

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,489.8492

F3 · price: Represents the weighted average price of the shares sold ranging from a low of $503.43 to a high of $504.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 313 $504.66 $157,959.08
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 9

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,066.8492

F2 · price: Represents the weighted average price of the shares sold ranging from a low of $504.49 to a high of $504.75 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
SaleCommon Stock 1,000 $505.06 $505,059.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 8

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,379.8492

F1 · price: Represents the weighted average price of the shares sold ranging from a low of $505.00 to a high of $505.225 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 2,000 $79.54 $159,080.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 7

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,379.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Tax withholdingCommon Stock 293 $503.65 $147,569.45
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 6

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,379.8492

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 93 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 5

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,672.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 86 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 4

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,579.9492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 162 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 3

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,439.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 181 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 2

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,331.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:56 UTC
Turner Kathy VSenior Vice President
Exercise / conversionCommon Stock 210 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003223 · doc1.xml · nonDerivative · entry 1

Turner Kathy V · CIK 0001740719 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,150.8492

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:55 UTC
Smith Martin AlexanderExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 149 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003222 · doc1.xml · derivative · entry 3

Smith Martin Alexander · CIK 0001621358 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,846

Underlying: Common Stock · 149 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F2 · price: Not applicable.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:55 UTC
Smith Martin AlexanderExecutive Vice President
Tax withholdingCommon Stock 47 $503.65 $23,671.55
Disclosure

SEC source: 0001567619-23-003222 · doc1.xml · nonDerivative · entry 2

Smith Martin Alexander · CIK 0001621358 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:55 UTC
Smith Martin AlexanderExecutive Vice President
Exercise / conversionCommon Stock 149 $0.00 $0.00
Disclosure

SEC source: 0001567619-23-003222 · doc1.xml · nonDerivative · entry 1

Smith Martin Alexander · CIK 0001621358 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:54 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 204 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003221 · doc1.xml · derivative · entry 11

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,155

Underlying: Common Stock · 204 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F6 · price: Not applicable.

F5 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

F5 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:54 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 161 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003221 · doc1.xml · derivative · entry 10

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,359

Underlying: Common Stock · 161 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F6 · price: Not applicable.

F4 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

F4 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:54 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 216 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003221 · doc1.xml · derivative · entry 9

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,520

Underlying: Common Stock · 216 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F6 · price: Not applicable.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:54 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 127 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003221 · doc1.xml · derivative · entry 8

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,736

Underlying: Common Stock · 127 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F6 · price: Not applicable.

F2 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

F2 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.

Read SEC document
February 14, 2023 Filed Feb 16, 2023 23:54 UTC
POLEWACZYK JAMES FExecutive Vice President
Exercise / conversionRestricted Stock Unit · Derivative 126 Not disclosed Not disclosed
Disclosure

SEC source: 0001567619-23-003221 · doc1.xml · derivative · entry 7

POLEWACZYK JAMES F · CIK 0001389046 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,863

Underlying: Common Stock · 126 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

F6 · price: Not applicable.

F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.